Brekasp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-06-14
Share capital
150,000.00 PLN
Registered address
al. Grunwaldzka 56/113, 80-241 Gdańsk, Poland

Financials

Total Operating Costs
328.74k
+953.6% vs 2020

Revenue history (in k)

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 698 days for 2019).

  • 2022not filed
  • 202113/09/2022
  • 202013/09/2022
  • 201913/09/2022
  • 201812/07/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue
This companyUSD 328.86kMedianUSD 164.14kAverageUSD 2.27m
Net profit
This companyUSD 109.31MedianUSD 1.03kAverageUSD 108.21k
Operating costs
This companyUSD 328.74kMedianUSD 187.05kAverageUSD 2.07m
Assets
This companyUSD 38.93kMedianUSD 115.76kAverageUSD 1.52m

Authorized Representatives

Seweryn Sroka – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Seweryn Srokaage 44
100$40,518.64100%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2021-03-25 to 2023-04-26.

Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)

Debt

2 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Jun 6, 2024
Discontinued enforcement proceedings
Closed
Dec 22, 2023
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
Apr 2, 2025Dissolution without liquidation opened
Nov 20, 2023Dissolution without liquidation opened

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Zakłady Farmaceutyczne PolpharmaS.A.
Labofarmsp. z o.o.
PoltregS.A.
Human BiomeS.A.
Natur DayS.A.
Biotriosp. z o.o.
Nature's Voicesp. z o.o.
Pexon Polandsp. z o.o.
Bioresearch PharmaS.A.
Grupa FinepharmS.A.

Change history

DateEvent
2021-03-19Address change
2021-03-19PKD change
2019-12-09Address change
2018-06-14Entered in the register

FAQ

Last updated: 2026-10-07